Multi-Omics Approach to Personalized Therapy Shows Feasibility in Metastatic Breast Cancer
A multi-omics approach to personalized therapy that incorporates information about actionable oncogenic drivers with critical biological data has demonstrated feasibility in patients metastatic breast cancer vs DNA sequencing alone.